Continuous Glucose Monitoring Goes Wireless

Following setup, the system provides continuous readings on the rate and direction of glucose change up to every five minutes, supporting therapy adjustments and treatment recommendations made by the healthcare practitioner. Features include single digit mean absolute relative difference (MARD), customizable alerts, and a built-in low glucose (55 mg/dL) alarm.

Users can select up to five designated recipients to remotely monitor their glucose information and receive alert notifications. Data from the Dexcom G5 Mobile can also be integrated with the Dexcom CLARITY cloud-based reporting software, for a personalized, easy-to-understand analysis of trends to improve diabetes management. The Dexcom G5 Mobile CGM is a product of Dexcom (San Diego, CA, USA), and has been approved by the US Food and Drug Administration (FDA). It is currently available for iOS-enabled devices, with Android availability slated for 2016.

“Dexcom is rapidly advancing technology for continuous glucose monitoring devices to improve diabetes management. These advances are making diabetes management more convenient and flexible than ever before,” said Kevin Sayer, president and CEO of Dexcom. “We are excited for the promise this new technology holds for patients and caregivers.”
CGM is considered the most significant breakthrough in diabetes management in the past 40 years, augmenting the use of traditional finger-stick glucose meters. In addition to providing a current glucose reading, CGM provides the direction and rate of glucose level changes, alerting users when glucose is too low or too high. Standard meters are still required to calibrate CGMs and for guidance in making therapy and meal decisions.

Related Links:
Dexcom